Dr. Nistala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1020 Hitt Street
Columbia, MO 65212Phone+1 573-882-8788Fax+1 573-882-3131
Education & Training
- University of Missouri-ColumbiaFellowship, Nephrology, 2008 - 2010
- University of Missouri-ColumbiaResidency, Internal Medicine, 2005 - 2008
- Grant Medical CollegeClass of 1995
Certifications & Licensure
- MO State Medical License 2009 - 2025
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow of American Heart Association AHA
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 61 citationsDipeptidyl peptidase-4 inhibition ameliorates western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic ...Annayya R. Aroor, Javad Habibi, David A. Ford, Ravi Nistala, Guido Lastra
Diabetes. 2015-06-01 - 232 citationsAngiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle CellsYongzhong Wei, James R. Sowers, Ravi Nistala, Heping Gong, Grace M. Uptergrove
The Journal of Biological Chemistry. 2006-11-17 - 109 citationsGlycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter, Javad Habibi, Guanghong Jia
Cardiovascular Diabetology. 2018-07-30
Grant Support
- Role of DPP4 in kidney injury and inflammationNIDDK2019–2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: